PHOENIX, 5/1/14 – Arizona Governor Jan Brewer signed House Bill 2078 into law Wednesday, making Arizona the 32nd state in the United States to have cost-parity for oral anticancer drugs. Beginning January 1, 2016, HB2078, sponsored by Representative Heather Carter (LD15), requires health insurance companies with plans that cover intravenous (IV) anticancer treatments and oral anticancer treatments to not discriminate against oral treatments by way of higher co-payments, deductibles or coinsurance.Continue reading
Category Archives: AZBio News
Man Without a Human Heart Completes 4.2-Mile Run
Randy Shepherd, Kept Alive for 10 Months by the SynCardia Total Artificial Heart Powered by the Freedom Portable Driver, Walked the April 26, 2014 Long-Distance Course Honoring Pat TillmanContinue reading
PanAridus Patents Eight New Strains of Guayule
CASA GRANDE, Ariz.—PanAridus, an agribusiness development firm specializing in the natural rubber-producing desert shrub guayule, has patented eight new strains of guayule, according to the company.Continue reading
Castle Biosciences announces results of Mesothelioma Molecular Test
Castle Biosciences’ Mesothelioma Molecular Test Accurately Stratifies Survival Risk Under Surgical and Non-Surgical Treatment Plans
Presentation at the American Association for Thoracic Surgery 94th Annual Meeting
DecisionDx-Mesothelioma test now available through early access programContinue reading
University of Arizona Steele Center to Study Preventing Deadly Intestinal Disease in Premature Babies
The study will expand Dr. Melissa Halpern’s previous research findings that identified changes in intestinal bile acid levels in neonatal rats that develop NEC, compared with those that did not develop the disease.Continue reading
Job Alert: Senior Research Development and Commercialization Associate at NAU
Company:
Northern Arizona University
Position:
Senior Research Development and Commercialization Associate
Job Description:
The Senior Research Development and Commercialization Associate is charged with sourcing, building and maintaining strong, productive relationships with faculty, staff and student researchers and innovators-as well as with existing/prospective licensees, industry partners, entrepreneurs, and the local, regional and national innovation management community-for the purpose of catalyzing research and technology development and pushing university innovations from the lab to the marketplace. The Senior Research Development and Commercialization Associate participates in decision-making associated with institutional-level research investments and also manages an assigned portfolio of technologies from initial invention disclosure through the commercial life of the technologies. Reports to the Chief of Staff, Office of the Vice President for Research and Director of NAU Innovations (one individual).
To learn more and apply, please click here.
Michael S. Gordon, MD named medical director for Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare
Will oversee Virginia G. Piper Cancer Center’s internationally recognized Phase I clinical trials programContinue reading
GSK Buys Novartis Vaccine Business
GSK announces major 3-part transaction with Novartis to drive sustainable sales growth, improve long-term earnings and deliver increasing returns to shareholdersContinue reading
ASU engineers help make advances in virtual artificial heart implantation
Some firsts in the history of artificial heart implantation are being achieved by an Arizona State University research group and medical professionals at Phoenix Children’s Hospital.Continue reading
A Conversation with Lee Hartwell: ‘This is the era of DNA’
It’s not every day that you get the chance to sit down face-to-face with a Nobel Laureate. But that’s exactly what happened on Tuesday, April 22, 2014, when about 150 Arizona biotechnology movers and shakers shook it up with Leland “Lee” Hartwell, PhD, at the AZBio Leadership Conversation luncheon at the Phoenix Country Club.Continue reading